Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
No major adverse effects have been documented in short-term preclinical or veterinary studies, but data on long-term human use remains limited. Crescioli, Clinical Peptides Safety and Biological Considerations One of the primary concerns around TB-500 is its ability to stimulate angiogenesis the formation of new blood vessels
PubMed, Jones, Bridgette L., et al
No, neither peptide is approved for general therapeutic use
This scar-breaking mechanism complements the tissue repair capabilities of other peptides and could theoretically work synergistically with remyelination-promoting compounds like TB4
US$ 20.32
US$ 26.33
US$ 28.43
